MedTrace Logo

Optimal Heating Temperature in Major Burns Patients

NCT04396951 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2020-05-21

No results posted yet for this study

Summary

pre and post intervention quasi-experimental epidemiological study without a control group will be carried out in large burned patients that will evaluate the influence on metabolic expenditure of the inclusion of active external rewarming in the control of body temperature.

Conditions

  • Burns
  • Thermal Injury
  • Nurse's Role

Interventions

DEVICE

Active external overheating with heating plate, Aragonia ® MTC 400

It is a heating device that is adjustable in height up to 50 cm from the patient and generates radiant heat at low temperature (up to 39 ◦C) distributed evenly. It is equipped with an adjustable 0-9 potentiometer and has a skin temperature probe as a control and safety mechanism Measure during 6 hours with indirect calorimetry in first week

DEVICE

Active external overheating with air blanket, Equator Level 1® de Smiths Medical

Composed of a unit that produces hot air and forced air adjustable from 38ºC to 43ºC. Sends hot forced air distributed by tubular blanket that convectively heats the patient by diffusing hot air directed at the patient through the textile pore of the air blanket Measure during 6 hours with indirect calorimetry in first week

Sponsors & Collaborators

  • University of Valladolid

    collaborator OTHER

  • Sanidad de Castilla y León

    collaborator OTHER

  • University Rovira i Virgili

    lead OTHER

Principal Investigators

  • Juan Manuel Alonso Fernández, MSN · Sanidad Castilla y León

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2022-03-01
Completion
2022-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04396951 on ClinicalTrials.gov